It may sound too devastating to be true, but some surgical mesh devices, including Bard Avaulta products, implanted in the vaginal walls of women to help alleviate pelvic organ prolapse (POP) and stress urinary incontinence (SUI) have caused serious health complications and physical injury.
The West Virginia Record reports that lawsuits are pending regarding surgical mesh devices causing organ injury in women. Requests were made to the U.S. Judicial Panel on Multi District Litigation last month to assign all 34 mesh complication cases, in addition to two from other districts, from Georgia to West Virginia. Attorneys making the request believe that the District Judge in West Virginia has become more acquainted with the issues at hand and the situation of the parties involved through pretrial handling of consolidated cases in his court.
The women filing surgical mesh injury lawsuits are seeking damages from C.R. Bard, Inc., the manufacturer and seller of Avaulta Plus and Avaulta Solo synthetic surgical mesh tissue supports. Some of the plaintiffs are also seeking damages from Covidien Inc., which manufactures Avaulta mesh supports.
The FDA issued a public health warning in October 2008 regarding serious Bard Avaulta surgical mesh complications. Over 1,000 reports from nine surgical mesh manufacturers about complications connected to surgical mesh devices have been reported to the FDA.
Some of the most frequently reported complications associated with surgical mesh devices used to alleviate POP and SUI symptoms include the mesh eroding into the vaginal wall; pain; urinary problems; discomfort during sexual intercourse; infection; bowel, bladder, and blood vessel damage; and recurrence of the prolapsed organs and incontinence. Some women have even required additional surgeries to either remove the surgical mesh or provide drainage of hematomas or abscesses, IV therapy, and blood transfusions.